These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20396720)
1. Effect of combination of anticytokine preparations anaferon and artrofoon on immune inflammation in rheumatoid arthritis. Petrov VI; Babaeva AR; Solodenkova KS; Cherevkova EV; Zabolotneva YA; Kachanova MV; Sergeeva SA Bull Exp Biol Med; 2009 Sep; 148(3):489-92. PubMed ID: 20396720 [TBL] [Abstract][Full Text] [Related]
2. Potentiated antibodies to tumor necrosis factor-alpha in the therapy of patients with rheumatoid arthritis. Kozlovskaya LV; Mukhin NA; Rameev VV; Sarkisova IA; Epstein OI Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():152-4. PubMed ID: 12949685 [TBL] [Abstract][Full Text] [Related]
3. Efficiency of potentiated antibodies to tumor necrosis factor-alpha (Artrofoon) in the therapy of patients with rheumatoid arthritis. Petrov VI; Babaeva AR; Cherevkova EV; Epstein OI; Sergeeva SA Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():155-8. PubMed ID: 12949686 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacotherapy of rheumatoid arthritis in the era of genetically engineered biological preparations]. Nasonov EL Ter Arkh; 2007; 79(5):5-8. PubMed ID: 17672066 [No Abstract] [Full Text] [Related]
5. Efficacy of rituximab in patients with rheumatoid arthritis refractory or with contra-indication to anti-tumor necrosis factor-alpha drugs in daily practice: an open label observational study. Assous N; Gossec L; Dougados M; Kahan A; Allanore Y Clin Exp Rheumatol; 2007; 25(3):504. PubMed ID: 17631755 [No Abstract] [Full Text] [Related]
7. [TNF-inhibitors slow down joint destruction in rheumatoid arthritis. No cure, but dramatic relief of symptoms]. Wollheim FA Lakartidningen; 2001 May; 98(21):2560-2. PubMed ID: 11433990 [No Abstract] [Full Text] [Related]
8. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195 [TBL] [Abstract][Full Text] [Related]
10. Anticytokine therapy--a new era in the treatment of rheumatoid arthritis? O'Dell JR N Engl J Med; 1999 Jan; 340(4):310-2. PubMed ID: 9920958 [No Abstract] [Full Text] [Related]
11. [Infliximab for therapy of rheumatoid arthritis]. Amano K Nihon Rinsho; 2005 Jan; 63 Suppl 1():517-20. PubMed ID: 15799410 [No Abstract] [Full Text] [Related]
12. Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis. Wisniacki N; Amaravadi L; Galluppi GR; Zheng TS; Zhang R; Kong J; Burkly LC Clin Ther; 2013 Aug; 35(8):1137-49. PubMed ID: 23928094 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficiency and tolerability of artrofoon in patients with rheumatoid arthritis associated with osteopenic syndrome. Peshekhonova LK; Chernov YN; Barsukova NA; Peshekhonov DV Bull Exp Biol Med; 2009 Sep; 148(3):468-9. PubMed ID: 20396714 [TBL] [Abstract][Full Text] [Related]
14. Adalimumab for rheumatoid arthritis? Ebell M; Kripke C Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667 [No Abstract] [Full Text] [Related]
15. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents. Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227 [No Abstract] [Full Text] [Related]